FIVE Form 144: 1,500 RSU Shares Planned Sale via Morgan Stanley ($216,615)
Rhea-AI Filing Summary
Five Below, Inc. (FIVE) filed a Form 144 reporting a proposed sale of 1,500 common shares through Morgan Stanley Smith Barney, with an aggregate market value of $216,615.00. The filing lists approximately 55,058,005 shares outstanding and an approximate sale date of 08/28/2025 on NASDAQ. The securities were acquired as restricted stock units on 03/01/2022 and the filer indicates the shares were granted by the issuer. The filing also discloses recent 10b5-1 sales by George S. Hill totaling 6,000 shares in the past three months: 4,500 sold on 06/05/2025 for $598,200.00 and 1,500 sold on 07/17/2025 for $210,000.00. The notice includes the filer’s representation that no undisclosed material adverse information is known to the seller.
Positive
- Clear regulatory disclosure: Form 144 provides required details on the proposed sale, acquisition date, and broker.
- Use of 10b5-1 plans: Recent sales were executed under 10b5-1, indicating prearranged trading instructions that can reduce information-timing concerns.
Negative
- Insider selling disclosed: The filer has sold 6,000 shares in the past three months, which investors may view negatively even though amounts are small relative to outstanding shares.
Insights
TL;DR: Routine Form 144 insider sale of RSUs under a 10b5-1 framework; disclosure complies with rule requirements.
The filing documents a proposed open-market sale of 1,500 common shares by an insider, acquired as restricted stock units in March 2022. Recent 10b5-1 sales totaling 6,000 shares in the last three months are disclosed, showing the insider has been executing prearranged sales. From a governance standpoint this is a standard compliance disclosure: the seller affirms lack of undisclosed material information and specifies the transaction mechanics and broker. The filing does not state the insider’s role or any change in relationship to the issuer, and it contains no operational or financial metrics about the company itself.
TL;DR: Insider sales are small relative to outstanding shares and appear procedural rather than company-impacting.
The reported proposed sale (1,500 shares, $216,615) and the recent executed sales (total 6,000 shares for $808,200) represent a very small fraction of the issuer’s ~55.06 million outstanding shares (0.011% combined). The securities were granted as RSUs, and sales are being routed through Morgan Stanley Smith Barney. Given the magnitude relative to float, these transactions are unlikely to be materially dilutive or valuation-moving by themselves. The filing contains no earnings, guidance, or material corporate developments.